Dostawy leków onkologicznych oraz różnych.
8 suppliers awarded•12 lots awarded•€2.89M awarded
Buyer: Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie / Rzeszów, Poland
Awarded value
€2.89M
Estimated value
€2.89M
Awarded at 100% of estimated value
Award date
Feb 05, 2024
Winners
8
Lots awarded
12
Winners
Wrocław, POL
€1.0M This contract
94 award notices•176 awarded lots•€141.86M total
Warszawa, POL
€439,432 This contract
55 award notices•99 awarded lots•€50.79M total
Toruń, POL
€427,805 This contract
1 award notice•1 awarded lot•€427,805 total
Warszawa, POL
€387,827 This contract
75 award notices•245 awarded lots•€91.38M total
WARSZAWA, POL
€275,859 This contract
86 award notices•119 awarded lots•€28.60M total
Warszawa, POL
€272,602 This contract
56 award notices•88 awarded lots•€20.77M total
Warszawa, POL
€24,973 This contract
52 award notices•112 awarded lots•€24.88M total
Warszawa, POL
€23,819 This contract
37 award notices•67 awarded lots•€8.93M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0002 | ASCLEPIOS Sp. akcyjna | €639,800 | Antineoplastic agents (33652100) | |
| LOT-0009 | Komtur Polska Sp. z o. o. | €439,432 | Pharmaceutical products (33600000) | |
| LOT-0011 | Neuca Spółka Akcyjna | €427,805 | Antineoplastic agents (33652100) | |
| LOT-0005 | ASCLEPIOS Sp. akcyjna | €386,365 | Antineoplastic agents (33652100) | |
| LOT-0010 | Baxter Polska Sp. z o.o. | €325,869 | Antineoplastic agents (33652100) | |
| LOT-0006 | Janssen - Cilag Polska Sp. z o.o. | €275,859 | Antineoplastic agents (33652100) | |
| LOT-0001 | Sanofi Sp. z o.o. | €272,602 | Antineoplastic agents (33652100) | |
| LOT-0012 | Baxter Polska Sp. z o.o. | €46,024 | Antineoplastic agents (33652100) | |
| LOT-0007 | Baxter Polska Sp. z o. o. | €24,973 | Pharmaceutical products (33600000) | |
| LOT-0008 | Pfizer Trading Polska Sp. z o.o. | €23,819 | Pharmaceutical products (33600000) | |
| LOT-0003 | Baxter Polska Sp. z o.o. | €15,934 | Pharmaceutical products (33600000) | |
| LOT-0004 | ASCLEPIOS Sp. akcyjna | €8,015 | Pharmaceutical products (33600000) |